Market Overview

Dan Nathan Sees Unusual Options Activity In Biotech ETF

Related XBI
Dan Nathan Sees Unusual Options Activity In XBI
The Companies That Led 2017's Biotech Rally
How You Can Enjoy The Huge Boom Coming To Biotech (Bret Jensen) (Seeking Alpha)

Dan Nathan said on CNBC's "Options Action" that put volume was really high in SPDR S&P Biotech (ETF) (NYSE: XBI) on Thursday. Puts outnumbered calls 3 to 1 as there were several large trades.

When the stock was trading at $74.65, there was a buyer of 10,000 contracts of the September 74/68 put spreads. The trader paid $1.67 for them, which sets the break even for the trade at $72.33 at the September expiration. The trade is going to reach its maximal profit of $4.33, if the stock drops to $68 or lower.

Posted-In: Dan Nathan Options ActionCNBC Sector ETFs Media ETFs


Related Articles (XBI)

View Comments and Join the Discussion!